A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases

With over 60 different disorders and a combined incidence occurring in 1:5000–7000 live births, lysosomal storage diseases (LSDs) represent a major public health problem and constitute an enormous burden for affected individuals and their families. Several reasons make the diagnosis of LSDs an arduo...

Full description

Bibliographic Details
Main Authors: Valentina La Cognata, Sebastiano Cavallaro
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/11/1750
_version_ 1797510238900846592
author Valentina La Cognata
Sebastiano Cavallaro
author_facet Valentina La Cognata
Sebastiano Cavallaro
author_sort Valentina La Cognata
collection DOAJ
description With over 60 different disorders and a combined incidence occurring in 1:5000–7000 live births, lysosomal storage diseases (LSDs) represent a major public health problem and constitute an enormous burden for affected individuals and their families. Several reasons make the diagnosis of LSDs an arduous task for clinicians, including the phenotype and penetrance variability, the shared signs and symptoms, and the uncertainties related to biochemical enzymatic assay results. Developing a powerful diagnostic tool based on next generation sequencing (NGS) technology may help reduce the delayed diagnostic process for these families, leading to better outcomes for current therapies and providing the basis for more appropriate genetic counseling. Herein, we employed a targeted NGS-based panel to scan the coding regions of 65 LSD-causative genes. A reference group sample (<i>n</i> = 26) with previously known genetic mutations was used to test and validate the entire workflow. Our approach demonstrated elevated analytical accuracy, sensitivity, and specificity. We believe the adoption of comprehensive targeted sequencing strategies into a routine diagnostic route may accelerate both the identification and management of LSDs with overlapping clinical profiles, producing a significant reduction in delayed diagnostic response with beneficial results in the treatment outcome.
first_indexed 2024-03-10T05:28:45Z
format Article
id doaj.art-a48ccc852a834213ae732c5df9846587
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T05:28:45Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-a48ccc852a834213ae732c5df98465872023-11-22T23:28:17ZengMDPI AGGenes2073-44252021-10-011211175010.3390/genes12111750A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage DiseasesValentina La Cognata0Sebastiano Cavallaro1Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 95126 Catania, ItalyInstitute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 95126 Catania, ItalyWith over 60 different disorders and a combined incidence occurring in 1:5000–7000 live births, lysosomal storage diseases (LSDs) represent a major public health problem and constitute an enormous burden for affected individuals and their families. Several reasons make the diagnosis of LSDs an arduous task for clinicians, including the phenotype and penetrance variability, the shared signs and symptoms, and the uncertainties related to biochemical enzymatic assay results. Developing a powerful diagnostic tool based on next generation sequencing (NGS) technology may help reduce the delayed diagnostic process for these families, leading to better outcomes for current therapies and providing the basis for more appropriate genetic counseling. Herein, we employed a targeted NGS-based panel to scan the coding regions of 65 LSD-causative genes. A reference group sample (<i>n</i> = 26) with previously known genetic mutations was used to test and validate the entire workflow. Our approach demonstrated elevated analytical accuracy, sensitivity, and specificity. We believe the adoption of comprehensive targeted sequencing strategies into a routine diagnostic route may accelerate both the identification and management of LSDs with overlapping clinical profiles, producing a significant reduction in delayed diagnostic response with beneficial results in the treatment outcome.https://www.mdpi.com/2073-4425/12/11/1750lysosomal storage disease (LSDs)diagnosistargeted next generation sequencing (tNGS)
spellingShingle Valentina La Cognata
Sebastiano Cavallaro
A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
Genes
lysosomal storage disease (LSDs)
diagnosis
targeted next generation sequencing (tNGS)
title A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
title_full A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
title_fullStr A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
title_full_unstemmed A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
title_short A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
title_sort comprehensive targeted ngs approach to assessing molecular diagnosis of lysosomal storage diseases
topic lysosomal storage disease (LSDs)
diagnosis
targeted next generation sequencing (tNGS)
url https://www.mdpi.com/2073-4425/12/11/1750
work_keys_str_mv AT valentinalacognata acomprehensivetargetedngsapproachtoassessingmoleculardiagnosisoflysosomalstoragediseases
AT sebastianocavallaro acomprehensivetargetedngsapproachtoassessingmoleculardiagnosisoflysosomalstoragediseases
AT valentinalacognata comprehensivetargetedngsapproachtoassessingmoleculardiagnosisoflysosomalstoragediseases
AT sebastianocavallaro comprehensivetargetedngsapproachtoassessingmoleculardiagnosisoflysosomalstoragediseases